Exploiting a (13)C-labelled heparin analogue for in situ solid-state NMR investigations of peptide-glycan interactions within amyloid fibrils

Org Biomol Chem. 2009 Jun 7;7(11):2414-20. doi: 10.1039/b820808e. Epub 2009 Mar 31.

Abstract

Pathological amyloid deposits are mixtures of polypeptides and non-proteinaceous species including heparan sulfate proteoglycans and glycosaminoglycans (GAGs). We describe a procedure in which a (13)C-labelled N-acetyl derivative of the GAG heparin ([(13)C-CH(3)]NAcHep) serves as a useful probe for the analysis of GAG-protein interactions in amyloid using solid-state nuclear magnetic resonance (SSNMR) spectroscopy. NAcHep emulates heparin by enhancing aggregation and altering the fibril morphology of Abeta(1-40), one of the beta-amyloid polypeptides associated with Alzheimer's disease, and alpha-synuclein, the major protein component of Lewy bodies associated with Parkinson's disease. (13)C SSNMR spectra confirm the presence of [(13)C-CH(3)]NAcHep in Abeta(1-40) fibril deposits and detect dipolar couplings between the glycan and arginine R(5) at the Abeta(1-40) N-terminus, suggesting that the two species are intimately mixed at the molecular level. This procedure provides a foundation for further extensive investigations of polypeptide-glycan interactions within amyloid fibrils.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / metabolism*
  • Amyloid / chemistry
  • Amyloid / metabolism*
  • Amyloid / ultrastructure
  • Amyloid beta-Peptides / metabolism
  • Carbon Isotopes
  • Heparin / analogs & derivatives*
  • Heparin / analysis
  • Heparin / metabolism*
  • Humans
  • Nuclear Magnetic Resonance, Biomolecular / methods*
  • Parkinson Disease / metabolism*
  • alpha-Synuclein / metabolism

Substances

  • Amyloid
  • Amyloid beta-Peptides
  • Carbon Isotopes
  • alpha-Synuclein
  • Heparin